Literature DB >> 30191044

Pathway of care of hepatocellular carcinoma in 2017.

Federica Invernizzi1,1, Massimo Colombo2,2.   

Abstract

Entities:  

Keywords:  chemo-embolization; hepatic resection; hepatocellular carcinoma; liver transplantation; medical therapy; radiofrequency ablation

Year:  2017        PMID： 30191044      PMCID： PMC6096445          DOI： 10.2217/hep-2017-0004

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  25 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment.

Authors:  Karim J Halazun; Rachel E Patzer; Abbas A Rana; Elizabeth C Verna; Adam D Griesemer; Ronald F Parsons; Benjamin Samstein; James V Guarrera; Tomoaki Kato; Robert S Brown; Jean C Emond
Journal:  Hepatology       Date:  2014-09-10       Impact factor: 17.425

3.  EASL Recommendations on Treatment of Hepatitis C 2016.

Authors: 
Journal:  J Hepatol       Date:  2016-09-22       Impact factor: 25.083

4.  Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort.

Authors:  Sahil Mittal; Fasiha Kanwal; Jun Ying; Randy Chung; Yvonne H Sada; Sarah Temple; Jessica A Davila; Hashem B El-Serag
Journal:  J Hepatol       Date:  2016-07-29       Impact factor: 25.083

Review 5.  Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.

Authors:  Ya Ruth Huo; Guy D Eslick
Journal:  JAMA Oncol       Date:  2015-09       Impact factor: 31.777

6.  Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma.

Authors:  Atsushi Sasaki; Seiichiro Kai; Yukio Iwashita; Seitaro Hirano; Masayuki Ohta; Seigo Kitano
Journal:  Cancer       Date:  2005-01-15       Impact factor: 6.860

7.  A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group.

Authors:  Guido Torzilli; Jacques Belghiti; Norihiro Kokudo; Tadatoshi Takayama; Lorenzo Capussotti; Gennaro Nuzzo; Jean-Nicolas Vauthey; Michael A Choti; Eduardo De Santibanes; Matteo Donadon; Emanuela Morenghi; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2013-05       Impact factor: 12.969

Review 8.  Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis.

Authors:  Annalisa Berzigotti; Maria Reig; Juan G Abraldes; Jaime Bosch; Jordi Bruix
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

9.  International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study.

Authors:  Stephen L Chan; Philip J Johnson; Frankie Mo; Sarah Berhane; Mabel Teng; Anthony W H Chan; Ming C Poon; Paul B S Lai; Simon Yu; Anthony T C Chan; Winnie Yeo
Journal:  Chin J Cancer       Date:  2014-09-16

10.  Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.

Authors:  Vincenzo Mazzaferro
Journal:  Hepatology       Date:  2016-02-26       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.